Study S001797

Safety and Efficacy of Oral Semaglutide in Hyperglycaemic Patients After Renal Transplantation

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05702931
Acronym: Sema-RTx
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: SINGLE
Status: RECRUITING
Enrollment: 104
Start: 2024-09-19
Primary completion: 2027-12
Lead sponsor: Copenhagen University Hospital, Rigshospitalet
Conditions: Hyperglycemia; Renal Transplant Complication Primary Non-Function; Diabetes
Interventions: DRUG:Semaglutide 14 MG [Rybelsus]; DRUG:Placebo
Results posted: FALSE

Registered primary outcomes

Mean sensor glucose (mmol/L) [14 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.